EuropaBio National Associations Council Summit 2023 (Spanish Presidency): A global Europe – the role of transformative legislation

Spain will hold the Presidency of the Council of the European Union for the fifth time in the second half of 2023, between July 1 and December 31. In a pivotal time for the Biotechnology industry, Spain will lead the dialogue on the European Commission’s proposal on new genomic techniques (NGT) and the revision of the Pharmaceutical Strategy for Europe – critical policies for European patients, Europe’s food security and the green transition.

EuropaBio – the European Association for Bioindustries and AseBio, the Spanish Association of Biotechnology Companies, are proud hosts of EuropaBio’s National Associations Council (NAC) annual Presidency Summit. Invited speakers from industry, policymakers, and national biotechnology associations will explore the latest policy developments and offer their insights into the upcoming work and ambitions of the Spanish Council Presidency.

The Summit will be public and held online on June 22. The event will be followed by a Summer reception on June 27 in Brussels to present our participants’ key messaging and recommendations.

If you wish to attend our session or have any questions, insights or suggestions, please do not hesitate to reach José Peres at j.peres@europabio.org.

Agenda

Opening remarks

• Tineke Van hooland, Deputy Secretary General at bio.be/essenscia, Chair of the National Associations Council (NAC) at EuropaBio

Panel I: Innovation for European Patients: the European pharmaceutical legislation

• MEP Dolors Montserrat (EPP)
• Ana Polanco, AseBio Chair of the Board, Head of European Government and Public Affairs, and Market Access and Pricing at Merck
• Dr Jessica Martinsson, Director General at SwedenBio
• Maria Pascual, Chief Regulatory Officer at Minoryx Therapeutics
• Moderation: Vlad Olteanu, Healthcare Public Affairs Director at EuropaBio

Panel II: Resilience, sustainability and competitiveness for Europe’s food chain: new genomic techniques

• Ilaria Ciabatti, Team Leader Biotechnology Unit, European Commission DG Santé
• Ion Arocena Vélez, Director General at AseBio – the Spanish Association of Biotechnology Companies
• Elke Duwenig, Senior Expert Global Regulatory / Public & Government Affairs Biotechnology, Nutrition & Health at BASF
• Oana Dima, Executive Manager of the EU-SAGE network, Science Policy Manager at VIB-Ghent University Center for Plant Systems Biology
• Tomasz Zimny, Assistant Professor at the Institute of Law Studies, Polish Academy of Sciences, Warszawa, Poland
• Ana Judith Martín de la Fuente, Head of Area/Secretary of the Interministerial Council of GMOs at the Spanish Ministry of Agriculture, Food and Fisheries
• Moderation: Anne-Gaelle Collot, Industrial Biotechnology Director at EuropaBio

Closing remarks

• Claire Skentelbery, Director General at EuropaBio